SUWANEE, GA, Sept. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is excited to announce the following conference plans for the fourth quarter consisting of 8 medical conferences.
SANUWAVE is very excited to be exhibiting and presenting at 8 of the top Wound Care trade seminars as we exit 2019. Since our FDA Clearance we have had increasing demand for the dermaPACE® system. “There is much the team has accomplished and we are pleased to showcase these accomplishments at the upcoming conferences. We have expanded our published peer reviewed articles. We have increased the number of posters by supporting further research within the wound care community. Given that our Pulsed Acoustic Cellular Expression (PACE®) therapy is relatively new to market, education is a must and has subsequently become increasingly important. To assist with learning, we have begun to sponsor more symposiums at various trade shows. These are intended to introduce clinicians to the dermaPACE system and allow for an open dialog with KOL’s using the device currently. We are very excited about a very busy schedule as increasing awareness and interest is driving clinician demand,” said Kevin Richardson, CEO.
North American Medical Conferences
SAWC – October 10 - 12 Las Vegas, NV - Caesars Palace, Las Vegas Nevada: Symposium on Advanced Wound Care Fall (SAWC Fall) meeting. This 3-day event serves as a forum to connect the entire wound care team—physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians—with the foremost experts in wound care to improve patient outcomes through education. No other wound care event offers the level of education, advanced state-of-the-art clinical reviews, and emerging research findings. SANUWAVE will be there in high profile at booth number - # 618.
SANUWAVE has a Lunch Symposium on Sunday October 13, 2019 11:20 – 12:20 PM in Room Julius 22-23. Adding to our popularity we have secured status as Complimentary Industry-Supported Symposium: CME/CNE/CECH-APPROVED Education Activity.
Title: Investigating the Effects of Focused Electrohydraulic Shockwave Therapy in Treatment of Diabetic Foot Ulcers: A Panel Discussion
- Dr. Oscar M Alvarez PhD CCT, FAPWCA, - Director U Hospital Wound Care Rutgers NJ Medical School
- Jayesh B Shah, MD, MHA, FACHM, FUHM, FACP, FAPWCCA, CWSP - Assistance Professor Division of Community and Family Medicine UT Health
- Mark S Granick, MD, FACS, - Professor of Surgery Medical Director U Hospital Wound Care Rutgers NJ Medical School
POSTER
Windy Cole
706631
The Use of Non-invasive Pulsed Acoustic Cellular Expression (PACE®) System to Promote Angiogenesis in Chronic Wounds
DFCon19 - October 17-19, 2019
2019 Diabetic Foot Global Conference
Hilton Los Angeles/Universal City, Universal City, CA
Keck School of Medicine of USC in collaboration with Baylor College of Medicine & University of California San Francisco.
DFCon is the premier international interdisciplinary diabetic foot conference in North America. Participants who number more than 400, delve into diagnostic and interventional strategies for diabetic foot ulcers and amputation prevention. Featuring a world-renowned international faculty. DFCon offers the opportunity to review state-of-the-art concepts and techniques. Booth # 1. We have submitted 3 abstracts that were accepted for poster presentation.
SANUWAVE® is a sponsor of a Breakfast Symposium on October 19th, 2019
TITLE: dermaPACE® role in avoiding amputation and treating DFU (TBA)
Moderator: Dr. Perry Mayer
Panelists: Dr. Brian Lepow
Dr. Anna Sanchez,
Dr. Lee Rogers
POSTERS
Aksone Nouvong
155
Effects of high energy acoustic shockwave therapy on local skin perfusion and healing of diabetic foot ulcers
Perry V Mayer
156
Extracorporeal shockwave therapy (ESWT)- PACE® technology: Micro-Vascular Stimulation Post-Amputation applied to Incision Lines Promotes Healing and Reduces Edema - Avoiding Extended Wound Care or the need for further Surgical Intervention
Brian Harper
157
ESWT -PACE® Technology Utilizes High-Energy Acoustic Pressure Shockwaves with Ultimate Goal of Regenerating Healthy Tissue in Chronic Foot Ulcers in a Community Clinic.
Wounds Canada – October 3rd to 6th 2019 – Niagara Falls, Ontario
Wounds Canada is the national organization in the country that services the wound care community as a benchmark for driving Best Practice, Innovation and Standardization. The National annual conference will be held October 3-6, 2019 in Niagara Falls Ontario. This year’s theme is Driving Change in Wound Care. Sanuwave is excited to actively participate. Sanuwave has submitted 4 abstracts that were accepted as Poster presentations. Our booth # is 511.
Posters
Aksone Nouvong.
37
Effects of high energy acoustic shockwave therapy on local skin perfusion and healing of diabetic foot ulcers
Windy Cole
36
The Use of Non-invasive Pulsed Acoustic Cellular Expression (PACE®) System to Promote Angiogenesis in Chronic Wounds
Iulian Cioanta
33
Pilot Study to Determine the Effects of Different Dosage Regimens of High Energy Acoustic Shockwaves in Treating Diabetic Foot Ulcers
Brian Harper
27
ESWT - PACE® Technology Utilizes High-Energy Acoustic Pressure Shockwaves with Ultimate Goal of Regenerating Healthy Tissue in Chronic Foot Ulcers in a Community Clinic.
First Nations - National Assembly Grand Chiefs Council Treaty #3 - Fall’s Assembly - at Wauzhusk Onigum Canada - September 30 to October 3, 2019.
Grand Council Treaty #3 enables the 28 member communities to discuss and decide on regional, federal and national priorities affecting First Nations health, and to provide a unified voice on health issues affecting its citizens. Kizhebowse Mukwa (Kind Walking Bear), Fred Kelly has made the introduction to Ogichidaa Francis Kavanaugh, Grand Chief and Gary Allen, Executive Director and Calvin Morrisseau Sr, Director of Health. SANUWAVE® has been invited to present dermaPACE® as a new non-invasive treatment for the purpose of helping those members of the community who suffer with diabetic wounds and face amputation.
International Shows
South Korea
October 5 ‘Wound healing Technology’ - Korea wound management society
November 22-23 ‘Korean foot & ankle society’
Italy
September 18-20 Lione (Fr) EPUAP 2019 https://epuap2019.org/: Dr. Cassino will be there to present a poster entitled: “A technology which saves time and costs”;
October 11-12 Bologna. SITOD (Italian shockwaves society) course. Matek opens the course with an hour workshop which titles: Matek presents SANUWAVE®’s technology. During these workshops we will introduce Sanuwave company and then Dr Lucchesi, orthopedics, will talk about the PACE® technology and Dr. Cassino about the wound healing with shockwaves. For this workshop there are already 40 specialists enrolled. We’ll be present during the 2-day course with a booth.
Below are Bios of some of the Key Opinion Leaders (KOL’s) presenting for Sanuwave
Windy Cole, DPM
Dr. Windy Cole is a native Ohioan. She holds a bachelor’s degree in biology from the University of Cincinnati and graduated with honors from the Kent State University College of Podiatric Medicine in 1999. Dr. Cole’s practice is located in Northeast Ohio where she serves as Medical Director of the Wound Care Center, University Hospitals Ahuja Medical Center and Adjunct Professor and Director of Wound Care Research at Kent State University College of Podiatric Medicine. She is a dedicated healthcare advocate with interests focused on medical education, diabetic foot care, wound care, limb salvage, clinical research and humanitarian efforts. Dr. Cole has published on these topics and is a sought-after speaker both nationally and internationally.
Brian Harper DCH
Brian Harper is a registered Chiropodist, foot specialist, with over 30 years of experience. Brian graduated from the Chiropody program at the Michener Institute in 1985 and is the clinical director for York Medical for the last 5 years. He was a former elected board member for the Ontario Society of Chiropodists (OSC), a founding board member of the Canadian Federation of Podiatric Medicine (CFPM) and former manager of the Chiropody at Scarborough Grace General Hospital.
Brian Lepow DPM
Dr Brian Lepow, DPM is a board-certified podiatric surgeon practicing in Houston, Texas specializing in Diabetic Foot Amputation Prevention and Limb Salvage. He maintains staff privileges at all major medical institutions in the Houston area. Dr. Lepow holds dual academic appointments in the departments of Internal Medicine and Cardiovascular Surgery at McGovern School of Medicine in Houston Texas as well as at the Baylor College of Medicine in the Division of Vascular Surgery and Endovascular Therapy.
Dr. Lepow is a native Houstonian. He graduated from Westbury High School and attended the University of Arizona in Tucson, Arizona. He earned his medical degree from Barry University School of Podiatric Medicine in Miami, Florida. Dr. Lepow completed his surgical residency training at The Mount Sinai Medical Center in New York, where he served as chief resident in Podiatric Medicine and Surgery. Following completion of his residency program he served as Fellow in Diabetic Limb Salvage and Reconstructive Surgery at the University of Arizona. In addition, Dr. Lepow held an academic appointment in the department of surgery at the University of Arizona College of Medicine.
Perry Mayer MD
Dr. Perry Mayer is the Medical Director of The Mayer Institute (TMI), a center of excellence for the treatment of the diabetic foot. He received his undergraduate degree from Queen’s University in Kingston, Ontario, Canada and medical degree from the Royal College of Surgeons in Ireland. He returned to Kingston in 1993 to practice family medicine and establish the Quarry Foot Clinic. In 2003, Dr. Mayer moved to Hamilton, Ontario and concentrated his time solely on the treatment of the diabetic foot. He formed The Mayer Institute in 2006. In the past year, TMI had over 16,000 patient visits, with over 12,000 visits being for diabetic wound care.
Lee C Rogers DPM
Dr. Rogers is a podiatrist, fellowship-trained in surgical limb salvage, who founded the first Amputation Prevention Center®. He is the author of more than 100 manuscripts and book chapters on the diabetic foot, including several that are designed to improve the process and protocols of treatment. He is the past chair of the Foot Care Council for the American Diabetes Association. Rogers received the 2011 Rising Star Award from the American Podiatric Medical Association for outstanding national accomplishments and he has been named by Podiatry Management Magazine as one of the most influential podiatrists in America. Rogers was selected as Educator of the Year by the California Podiatric Medical Association in 2012 and given the master’s Award from the American Professional Wound Care Association in 2013. Rogers’s work has been quoted in the Wall Street Journal, the Washington Post, U.S. News and World Report and he’s been a guest on ABC’s The Doctors Show.
Anna E. Sanchez, D.P.M.
Dr Anna E Sanchez is a Doctor of Podiatry Medicine. She is a Diabetic Foot Ulcer specialist in San Antonio, Texas. She went to Barry University School Podiatric Medicine and graduated in 1993 and has a master’s degree in biomedical sciences. Dr Sanchez has 26 years of diverse experience with area of expertise as Podiatry. She is Podiatrist/Owner of Del Rio Foot Clinic San Antonio, TX and Principal Investigator Element Research Group San Antonio, TX and Present Principal Investigator Bio-X-Cell Research, LLC.
Jay Shah MD
Award winning wound care and hyperbaric physician in active clinical practice. Columbia trained. Certified in Wound Management, Board Certified in Undersea and Hyperbaric Medicine, and Internal Medicine. Fellow of Undersea and Hyperbaric Medicine, American College of Physicians, Undersea and Hyperbaric Medicine, and American College of Clinical Wound Specialist. Extensive public speaking experience. President of American College of Hyperbaric Medicine. Former Chair for the American College of Certified Wound Specialists. Assistant Chief Editor, American College of Clinical Wound Specialist Journal. Editorial Board, Advance Wound Dressings Today. Past President of American Association of Physicians of Indian Origin. Immediate Past President of Bexar County Medical Society. Medical Expert Witness specializing in Wound Care/Nursing Home/Long Term Care.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. (OTCQB:SNWV) (www.SANUWAVE.com) is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body’s normal healing processes and regeneration. SANUWAVE applies its patented PACE® technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE®, is US FDA cleared for the treatment of Diabetic Foot Ulcers. The device is also CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, South Korea, Australia and New Zealand. SANUWAVE researches, designs, manufactures, markets and services its products worldwide, and believes it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through its U.S. Class III PMA approved OssaTron® device, as well as stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the utilization of its OssaTron, Evotron® and orthoPACE® devices in Europe, Asia and Asia/Pacific. In addition, there are license/partnership opportunities for SANUWAVE’s shockwave technology for non-medical uses, including energy, water, food and industrial markets.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
For additional information about the Company, visit www.sanuwave.com.
CONTACT: Contact: Millennium Park Capital LLC Christopher Wynne 312-724-7845 cwynne@mparkcm.com SANUWAVE Health, Inc. Kevin Richardson II CEO and Chairman of the Board 978-922-2447 investorrelations@sanuwave.com
